Wnt and mammary stem cells: Hormones cannot fly wingless

Current Opinion in Pharmacology

Volumn 10, Issue 6, 2010, Pages 643-649

  Roarty, Kevin ^a   Rosen, Jeffrey M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN; BETA CATENIN; ESTROGEN RECEPTOR; GLYCOGEN SYNTHASE KINASE 3BETA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; PROGESTERONE RECEPTOR; WNT PROTEIN;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL RENEWAL; COLON POLYPOSIS; HORMONAL REGULATION; HORMONE ACTION; LIGAND BINDING; MAMMARY STEM CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; STEM CELL MOBILIZATION;

ANIMALS; BETA CATENIN; BREAST; BREAST NEOPLASMS; DOWN-REGULATION; EPITHELIUM; ESTROGEN RECEPTOR ALPHA; FEMALE; HORMONES; HUMANS; LDL-RECEPTOR RELATED PROTEINS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; NEOPLASTIC STEM CELLS; RECEPTORS, PROGESTERONE; SIGNAL TRANSDUCTION; STEM CELLS; WNT PROTEINS;

EID: 78149500341     PISSN: 14714892     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coph.2010.07.004     Document Type: Review

References (50)

1. Brisken C., Duss S. Stem cells and the stem cell niche in the breast: an integrated hormonal and developmental perspective. Stem Cell Rev 2007, 3:147-156.
2. Visvader J.E. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009, 23:2563-2577.
3. Tanos T., Brisken C. What signals operate in the mammary niche?. Breast Dis 2008, 29:69-82.
4. Deome K.B., Faulkin L.J., Bern H.A., Blair P.B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female C3H mice. Cancer Res 1959, 19:515-520.
5. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-768.
6. Creighton C.J., Li X., Landis M., Dixon J.M., Neumeister V.M., Sjolund A., Rimm D.L., Wong H., Rodriguez A., Herschkowitz J.I., et al. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci U S A 2009, 106:13820-13825.
7. Watson C.J., Khaled W.T. Mammary development in the embryo and adult: a journey of morphogenesis and commitment. Development 2008, 135:995-1003.
8. LaMarca H.L., Rosen J.M. Minireview: hormones and mammary cell fate-what will I become when I grow up?. Endocrinology 2008, 149:4317-4321.
9. Clarke R.B., Howell A., Potten C.S., Anderson E. Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res 1997, 57:4987-4991.
10. Booth B.W., Boulanger C.A., Anderson L.H., Jimenez-Rojo L., Brisken C., Smith G.H. Amphiregulin mediates self-renewal in an immortal mammary epithelial cell line with stem cell characteristics. Exp Cell Res 2010, 316:422-432.
11. Ciarloni L., Mallepell S., Brisken C. Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc Natl Acad Sci U S A 2007, 104:5455-5460.
12. Beleut M., Rajaram R.D., Caikovski M., Ayyanan A., Germano D., Choi Y., Schneider P., Brisken C. Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland. Proc Natl Acad Sci U S A 2010, 107:2989-2994.
13. Brisken C., Heineman A., Chavarria T., Elenbaas B., Tan J., Dey S.K., McMahon J.A., McMahon A.P., Weinberg R.A. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 2000, 14:650-654.
14. Robinson G.W., Hennighausen L., Johnson P.F. Side-branching in the mammary gland: the progesterone-Wnt connection. Genes Dev 2000, 14:889-894.
15. Angers S., Moon R.T. Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 2009, 10:468-477.
16. van Amerongen R., Mikels A., Nusse R. Alternative wnt signaling is initiated by distinct receptors. Sci Signal 2008, 1:re9.
17. Gavin B.J., McMahon A.P. Differential regulation of the Wnt gene family during pregnancy and lactation suggests a role in postnatal development of the mammary gland. Mol Cell Biol 1992, 12:2418-2423.
18. Buhler T.A., Dale T.C., Kieback C., Humphreys R.C., Rosen J.M. Localization and quantification of Wnt-2 gene expression in mouse mammary development. Dev Biol 1993, 155:87-96.
19. Kouros-Mehr H., Werb Z. Candidate regulators of mammary branching morphogenesis identified by genome-wide transcript analysis. Dev Dyn 2006, 235:3404-3412.
20. Weber-Hall S.J., Phippard D.J., Niemeyer C.C., Dale T.C. Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. Differentiation 1994, 57:205-214.
21. Kendrick H., Regan J.L., Magnay F.A., Grigoriadis A., Mitsopoulos C., Zvelebil M., Smalley M.J. Transcriptome analysis of mammary epithelial subpopulations identifies novel determinants of lineage commitment and cell fate. BMC Genomics 2008, 9:591.
22. Lim E., Wu D., Pal B., Bouras T., Asselin-Labat M.L., Vaillant F., Yagita H., Lindeman G.J., Smyth G.K., Visvader J.E. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways. Breast Cancer Res 2010, 12:R21.
23. Miller RK, McCrea PD: Wnt to build a tube: contributions of Wnt signaling to epithelial tubulogenesis. Dev Dyn 239:77-93.
24. Roarty K., Serra R. Wnt5a is required for proper mammary gland development and TGF-beta-mediated inhibition of ductal growth. Development 2007, 134:3929-3939.
25. Bradbury J.M., Edwards P.A., Niemeyer C.C., Dale T.C. Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev Biol 1995, 170:553-563.
26. Brisken C., Park S., Vass T., Lydon J.P., O'Malley B.W., Weinberg R.A. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A 1998, 95:5076-5081.
27. Hiremath M., Lydon J.P., Cowin P. The pattern of beta-catenin responsiveness within the mammary gland is regulated by progesterone receptor. Development 2007, 134:3703-3712.
28. Imbert A., Eelkema R., Jordan S., Feiner H., Cowin P. Delta N89 beta-catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol 2001, 153:555-568.
29. Teissedre B., Pinderhughes A., Incassati A., Hatsell S.J., Hiremath M., Cowin P. MMTV-Wnt1 and -DeltaN89beta-catenin induce canonical signaling in distinct progenitors and differentially activate Hedgehog signaling within mammary tumors. PLoS One 2009, 4:e4537.
30. Gu B., Sun P., Yuan Y., Moraes R.C., Li A., Teng A., Agrawal A., Rheaume C., Bilanchone V., Veltmaat J.M., et al. Pygo2 expands mammary progenitor cells by facilitating histone H3 K4 methylation. J Cell Biol 2009, 185:811-826.
31. Hsu W., Shakya R., Costantini F. Impaired mammary gland and lymphoid development caused by inducible expression of Axin in transgenic mice. J Cell Biol 2001, 155:1055-1064.
32. Tepera S.B., McCrea P.D., Rosen J.M. A beta-catenin survival signal is required for normal lobular development in the mammary gland. J Cell Sci 2003, 116:1137-1149.
33. Lindvall C., Evans N.C., Zylstra C.R., Li Y., Alexander C.M., Williams B.O. The Wnt signaling receptor Lrp5 is required for mammary ductal stem cell activity and Wnt1-induced tumorigenesis. J Biol Chem 2006, 281:35081-35087.
34. Lindvall C., Zylstra C.R., Evans N., West R.A., Dykema K., Furge K.A., Williams B.O. The Wnt co-receptor Lrp6 is required for normal mouse mammary gland development. PLoS One 2009, 4:e5813.
35. Badders N.M., Goel S., Clark R.J., Klos K.S., Kim S., Bafico A., Lindvall C., Williams B.O., Alexander C.M. The Wnt receptor, Lrp5, is expressed by mouse mammary stem cells and is required to maintain the basal lineage. PLoS One 2009, 4:e6594.
36. Asselin-Labat M.L., Vaillant F., Sheridan J.M., Pal B., Wu D., Simpson E.R., Yasuda H., Smyth G.K., Martin T.J., Lindeman G.J., et al. Control of mammary stem cell function by steroid hormone signalling. Nature 2010, 465:798-802.
37. Joshi P.A., Jackson H.W., Beristain A.G., Di Grappa M.A., Mote P., Clarke C., Stingl J., Waterhouse P.D., Khokha R Progesterone induces adult mammary stem cell expansion. Nature 2010, 465:803-807.
38. Suzuki H., Toyota M., Carraway H., Gabrielson E., Ohmura T., Fujikane T., Nishikawa N., Sogabe Y., Nojima M., Sonoda T., et al. Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer. Br J Cancer 2008, 98:1147-1156.
39. Veeck J., Geisler C., Noetzel E., Alkaya S., Hartmann A., Knuchel R., Dahl E. Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis. Carcinogenesis 2008, 29:991-998.
40. Ugolini F., Charafe-Jauffret E., Bardou V.J., Geneix J., Adelaide J., Labat-Moleur F., Penault-Llorca F., Longy M., Jacquemier J., Birnbaum D., et al. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene 2001, 20:5810-5817.
41. Li Y., Welm B., Podsypanina K., Huang S., Chamorro M., Zhang X., Rowlands T., Egeblad M., Cowin P., Werb Z., et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A 2003, 100:15853-15858.
42. Liu B.Y., McDermott S.P., Khwaja S.S., Alexander C.M. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci U S A 2004, 101:4158-4163.
43. Shackleton M., Vaillant F., Simpson K.J., Stingl J., Smyth G.K., Asselin-Labat M.L., Wu L., Lindeman G.J., Visvader J.E. Generation of a functional mammary gland from a single stem cell. Nature 2006, 439:84-88.
44. Vaillant F., Asselin-Labat M.L., Shackleton M., Forrest N.C., Lindeman G.J., Visvader J.E. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008, 68:7711-7717.
45. Chen M.S., Woodward W.A., Behbod F., Peddibhotla S., Alfaro M.P., Buchholz T.A., Rosen J.M. Wnt/beta-catenin mediates radiation resistance of Sca1+ progenitors in an immortalized mammary gland cell line. J Cell Sci 2007, 120:468-477.
46. Woodward W.A., Chen M.S., Behbod F., Alfaro M.P., Buchholz T.A., Rosen J.M. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A 2007, 104:618-623.
47. Liu C.C., Prior J., Piwnica-Worms D., Bu G. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci U S A 2010, 107:5136-5141.
48. DiMeo T.A., Anderson K., Phadke P., Fan C., Perou C.M., Naber S., Kuperwasser C. A novel lung metastasis signature links Wnt signaling with cancer cell self-renewal and epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res 2009, 69:5364-5373.
49. Khramtsov A.I., Khramtsova G.F., Tretiakova M., Huo D., Olopade O.I., Goss K.H. Wnt/{beta}-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome. Am J Pathol 2010, 176:2911-2920.
50. Zeng Y.A., Nusse R. Wnt proteins are self-renewal factors for mammary stem cells and promote their long-term expansion in culture. Cell Stem Cell 2010, 6:568-577.